Liquidia Corporation (LQDA): Revenue Growth QoQ

Corporate company logo of Liquidia Corp (LQDA)

The fate of Liquidia Corporation (LQDA) in the orphan drug niche depends on victories in patent disputes with industry behemoths, and the quarterly revenue growth rate on GURU.Markets reflects these risks. The value of 315.40 represents the current level of the metric. Liquidia Corporation relies on protected distribution channels for inhalation agents, while the inertia of commercial implementation for pulmonary hypertension drugs ensures a stable financial inflow.

Liquidia Corp (LQDA) - Quarterly Revenue Growth from 07/04/2022 to 11/20/2026

Financial and market metric breakdowns for Liquidia (LQDA)

- stock price and consensus target price:
- cash and cash flow metrics:
Fundamental company analysis:Liquidia Inc. (LQDA)
Manufactured products of liquidia.com

Liquidia Corporation (LQDA) operates in a state of constant legal warfare over patents, rendering the commercial implementation of inhalation drugs dependent on judicial rulings. The calculated quarterly revenue growth rate mathematically captures the effectiveness of these adaptations by measuring the relative increase in sales cash flow compared to the previous period. By analyzing the quarterly revenue growth trend, an investor determines the fundamental vector of business expansion, separating market noise from real growth.

Competitors of Liquidia Corporation (LQDA)

HLN - Revenue Growth QoQ|Quarterly Revenue Growth Rate kenvue.com|Verona Pharma (VRNA) - Revenue Growth QoQ|Quarterly Revenue Growth Rate Jyong Biotech Limited (MENS)|LGND (Ligand Pharmaceuticals Incorporated) - Quarterly Revenue Growth|Quarterly Revenue Growth Rate Amneal Pharmaceuticals Inc AMRX|Quarterly Revenue Growth PRGO|Sales Change QoQ ALVO|Quarterly Revenue Growth GLPG (glpg.com)|Quarterly Revenue Increase ANIP|MNKD - Revenue Growth QoQ|Amphastar - Sales Change QoQ|PCRX: Quarterly Revenue Growth|ars-pharma.com - Quarterly Revenue Increase|TBPH (Theravance Biopharma Inc) - Quarterly Revenue Growth|Quarterly Revenue Growth Rate Aquestive Pharma AQST|Quarterly Revenue Growth SCPH|Sales Change QoQ TECX|Revenue Growth QoQ tonixpharma.com TNXP|SXTC (SXT China) - Revenue Dynamics QoQ|Eupraxia Pharmaceuticals - Quarterly Revenue Growth|Quarterly Sales Growth Rate BioHarvest Sciences Inc. BHST|EXOZ: Quarterly Revenue Growth|Oramed (ORMP) - Quarterly Revenue Growth|ENTX (Entera Bio) - Quarterly Revenue Growth|ipatherapeutics.com (HYFT) - Quarterly Sales Growth Rate|Quarterly Revenue Growth ABVC|CPIX (Cumberland Pharmaceuticals Inc) - Quarterly Revenue Increase|Revenue Growth QoQ Quantum BioPharma Corp QNTM|FibroGen Corporation (FGEN) - Quarterly Revenue Growth Rate|TELO: Quarterly Sales Growth|Quarterly Sales Growth Rate Rani Therapeutics Holdings, Inc. RANI|Synergy CHC Corp (SNYR) - Revenue Growth QoQ|RLYB - Quarterly Sales Growth Rate|Revenue Growth QoQ Lexaria Bioscience|Pulmatrix Corp - Revenue Dynamics QoQ|Revenue Growth QoQ ftzy.com.cn (PTHL)|Aptorum Group - Sales Growth QoQ|Quarterly Revenue Growth LYRA (Lyra Therapeutics Inc.)|Quarterly Sales Growth Rate Impact BioMedical (IBO)|TNF Pharmaceuticals - Quarterly Revenue Growth|Quarterly Revenue Growth Rate cbdMD Inc.|PainReform Ltd. (PRFX) - Revenue Growth QoQ|Quarterly Revenue Growth Rate Altamira Therapeutics (CYTO)|Revenue Growth QoQ Lipella Pharmaceuticals, Inc.|OPTN: Quarterly Revenue Increase|Revenue Growth QoQ Pieris (PIRS)|Quarterly Revenue Growth Procaps Group Corp (PROC)|Quarterly Revenue Growth PTPI (petrospharma.com)|Quarterly Revenue Increase QLI|ACELYRIN - Quarterly Revenue Growth|Quarterly Revenue Increase TFFP (TFF Pharmaceuticals Inc.)